Mr. Rav Mlait reports

CANNABIX TECHNOLOGIES ANNOUNCES COMMERCIAL LAUNCH OF MARIJUANA BREATH TEST (MBT)

Cannabix Technologies Inc. has commenced its commercial phased rollout of the marijuana breath test system. This phase includes the delivery of MBT units to select commercial customers across multiple industries, followed by a planned scale-up in production.

The marijuana breath test fills a critical gap, and delivers new technology and methods that provide a complete, non-invasive solution for detecting recent cannabis use, specifically delta-9 tetrahydrocannabinol (the primary psychoactive compound in cannabis) in breath, within approximately four hours of consumption at levels above five picograms per litre. This capability addresses a long-standing need among employers, law enforcement agencies and safety-sensitive industries, which have historically relied on testing methods that detect primarily past cannabis use. As legalized recreational and medical marijuana use continues to expand across the United States and globally, accurate detection of recent use by breath is becoming essential for maintaining fairness, relevance and informed decision making.

In early March, 2026, an independent peer-reviewed publication in the Journal of Analytical Toxicology became publicly available, confirming the ability of the MBT system to detect delta-9 THC.

Over recent months, Cannabix and its partners have completed many initiatives to enable the commercial rollout of the MBT system:

• Key enhancements to the breath collection unit and breath cartridges, along with the initial validation package prepared by Omega Laboratories Inc.;
• Integration of Cannabix breath cartridges into Omega's operational workflows, including chain-of-custody processes and electronic reporting through its laboratory information management system;
• Established manufacturing procedures and partnerships, standard operating procedures, and quality assurance/quality control processes for MBT hardware;
• BCU passing FCC electronic emission testing.
• The MBT system will follow a recurring revenue model in which the hand-held BCU serves as the required hardware for all deployments, while disposable breath cartridges generate continuing revenue as they are used for every test performed;
• Prelaunch marketing initiatives conducted with Omega (Ohio) and AlcoPro (Knoxville, Tenn.);
• Preparation of end-user training materials, logistics planning and customer support resources;
• Release of peer-reviewed Journal of Analytical Toxicology publication, titled: "Simultaneous Analysis of Delta9-THC, Delta8-THC, CBD and CBN in Breath Aerosols Collected Using Cannabix Technologies Breath Collection Unit" (March 2026).

The MBT platform consists of the Cannabix breath collection unit, disposable breath cartridges and the laboratory-developed test method by Omega Laboratories. Cannabix has a strategic partnership with Omega Laboratories, a global leader in forensic drug testing for over 25 years. Omega holds multiple federal and international certifications, and operates a world-class facility with extensive experience in novel drug detection technologies.

Why recent use detection of cannabis is important

Traditional cannabis testing methods such as urine, saliva or hair analysis primarily detect historical cannabis use. These methods can return positive results hours, days or even weeks after consumption, making them ineffective for determining whether an individual may be using during the workday.

Scientific research shows that delta-9 THC is detectable in breath for a short window of approximately two to four hours, closely aligned with the period of peak impairment. Breath analysis therefore provides the most relevant and scientifically meaningful indication of recent use, which is the metric employers and safety-sensitive industries require.

About Cannabix Technologies Inc.

Cannabix is a developer of marijuana and alcohol breath technologies for workplaces, law enforcement and other settings. The marijuana breath test targets delta-9 THC (the primary psychoactive ingredient in cannabis) in breath and focuses on recent marijuana use. Cannabix is the developer of the BreathLogix autonomous alcohol screening device for organizations which strive to improve alcohol safety and monitoring.

We seek Safe Harbor.